Jerry Leonard
20+
Years Financial Leadership
$90B
AUM Oversight at Voya
Big 4
PwC · Arthur Andersen
Nasdaq
Public Company CFO
Board Director & Financial Executive
Seasoned financial executive built for the boardroom.
Jerry currently serves as Chief Financial Officer of Vyome Holdings, Inc. (Nasdaq: HIND). Read the appointment announcement.
erry Leonard is a CPA, MBA, and CGMA with more than three decades of financial leadership spanning Big 4 audit, global corporate finance, investment management, and public company CFO roles. His career reflects a deliberate progression from technical rigor to enterprise-level governance.
As CFO of VSee Health, Inc., Jerry led a full SPAC lifecycle, from merger through Nasdaq listing, SEC registration, capital markets, and ongoing public company financial reporting. Prior to that, he served as VP of Finance at Voya Investment Management, overseeing finance functions for a firm managing approximately $90 billion in assets under management, where his financial models drove more than $3 billion in new assets and 55% revenue CAGR, and he delivered $20 million in technology cost savings.
His earlier career included global corporate audit leadership at IBM across the U.S., Asia Pacific, and Europe, and audit engagements at PricewaterhouseCoopers and Arthur Andersen. He holds an MBA from Emory University's Goizueta Business School.
Today, as Founder & CEO of ClearBridgeCFO, Jerry provides fractional CFO and financial transformation services to mid-market healthcare, telehealth, and SaaS companies, bringing board-caliber financial discipline to growth-stage organizations.

Core Competencies
What I bring to every board seat.
Effective board service demands executives who can translate financial complexity into governance clarity. My expertise spans the full spectrum of what audit committees and boards require.
⚖️
Audit Committee Readiness
Grounded in Big 4 audit at PwC and Arthur Andersen, and in leading finance and tax internal audits for IBM across the U.S., Asia Pacific, and Europe, where I found control weaknesses in global financing operations. As a sitting public company CFO, I work directly with audit committees and external auditors. I understand PCAOB standards, internal controls, risk oversight, and what makes an auditor relationship productive rather than adversarial.
📊
SEC Financial Reporting
I've prepared and filed 10-Ks, 10-Qs, 8-Ks, proxy statements, and S-1/S-4 registration statements across complex multi-entity structures, including audited GAAP financial statements and MD&A. Today, as CFO of Vyome Holdings (Nasdaq: HIND), I lead SEC reporting for a multinational group spanning the U.S., India, Australia, and Europe, working with auditors and legal counsel to deliver disclosures that investors and regulators can trust.
💰
Capital Markets & M&A
I led VSee Health through a full SPAC lifecycle, from the S-4 merger through Nasdaq listing, and then raised about $20M in post-listing capital to fund growth. I also handled warrant analysis, divestiture significance testing under SEC rules, and work with investors and bankers. At Vyome, I oversee the finance integration of a post-reverse-merger company. I bring transaction judgment to boards weighing raises, acquisitions, or exits.
🛡️
Crisis Leadership & Listing Compliance
When VSee Health faced a Nasdaq minimum stockholders' equity deficiency, I restructured the balance sheet and led a successful direct appeal to Nasdaq that resolved the deficiency and kept the company listed. Today I manage ongoing Nasdaq compliance as CFO of Vyome Holdings. Boards facing covenant breaches, going-concern questions, listing deficiencies, or restatement risk benefit from a director who has handled those situations firsthand.
🏥
Healthcare, Life Sciences & Technology
I have deep sector experience in telehealth, digital health, biotech, and SaaS. That includes redesigning revenue recognition for full ASC 606 compliance across software and healthcare service lines, along with ASC 842 lease accounting and CECL implementation. I drove 52% revenue growth at a key telehealth operating entity and now lead finance for a clinical-stage biotech, so I understand both the accounting complexity and the commercial drivers in these businesses.
🔄
Financial Transformation
At VSee Health, I led the move from Sage Intacct to Rillet, an AI-native ERP, cutting the month-end close from 30 days to 4. Invoicing 200 customers went from three days to five minutes, and AR posting, depreciation, and AP were automated with audit-ready schedules built in. Subsidiaries now close by day five, which keeps SEC filings on schedule. I bring that same discipline to boards overseeing finance modernization, technology investment, and the controls that come with it.
Board Director Value
Why boards benefit from this seat.
Boards seeking financial expertise, governance rigor, and executive accountability will find in Jerry Leonard a director who has been on both sides of the boardroom table.

Public Company Fluency
As a Nasdaq CFO, I navigated every dimension of public company governance — SEC reporting, investor relations, Sarbanes-Oxley compliance, and earnings communication. I understand what boards need because I have delivered it to them.
Audit Committee Expertise
My Big 4 foundation and decades of financial leadership position me to lead or serve on audit committees with deep credibility — evaluating external auditors, overseeing internal controls, and assessing financial risk with precision.
Industry Sector Depth
Healthcare, telehealth, SaaS, financial services, and technology — I bring vertical expertise that allows boards to move faster and with greater confidence on sector-specific strategy, risk, and regulatory matters.
Transformation Experience
Boards governing companies in transition — through capital raises, M&A, restructuring, or scale — benefit from an executive who has led through each of these inflection points and emerged with measurable results.
Committee Interests
Where I contribute most.
-
Audit Committee
-
Finance Committee
-
Risk & Compliance Committee
-
Compensation Committee
-
Technology Committee
-
Investment Committee
